These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 28844295)

  • 1. Concentrations in plasma clozapine levels in schizophrenic and schizoaffective patients.
    Iglesias García C; Iglesias Alonso A; Bobes J
    Rev Psiquiatr Salud Ment; 2017; 10(4):192-196. PubMed ID: 28844295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients.
    Consoli G; Lastella M; Ciapparelli A; Catena Dell'Osso M; Ciofi L; Guidotti E; Danesi R; Dell'Osso L; Del Tacca M; Di Paolo A
    Pharmacogenomics; 2009 Aug; 10(8):1267-76. PubMed ID: 19663671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia.
    Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS
    Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.
    Spina E; Avenoso A; Facciolà G; Scordo MG; Ancione M; Madia AG; Ventimiglia A; Perucca E
    Psychopharmacology (Berl); 2000 Jan; 148(1):83-9. PubMed ID: 10663421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-individual variation of clozapine and norclozapine plasma levels in clinical practice.
    Turrion MC; Perez J; Bernardo M; Fernandez-Egea E
    Rev Psiquiatr Salud Ment (Engl Ed); 2020; 13(1):31-35. PubMed ID: 31122757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma ratio of clozapine to N-desmethylclozapine can predict cognitive performance in treatment-resistant psychotic patients.
    Molins C; Carceller-Sindreu M; Navarro H; Carmona C; Piñeiro M; Martínez E; Álvarez E; Portella MJ
    Psychiatry Res; 2017 Dec; 258():153-157. PubMed ID: 29024893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clozapine-resistant schizophrenia related to an increased metabolism and benefit of fluvoxamine: four case reports].
    Papetti F; Morel-Pingault V; Buisse V; Maziere L; Banayan M; Thauby S; Besnard T; Darcourt G; Pringuey D
    Encephale; 2007 Oct; 33(5):811-8. PubMed ID: 18357853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia.
    Ozdemir V; Kalow W; Posner P; Collins EJ; Kennedy JL; Tang BK; Albers LJ; Reist C; Roy R; Walkes W; Afra P
    J Clin Psychopharmacol; 2001 Aug; 21(4):398-407. PubMed ID: 11476124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients.
    Kronig MH; Munne RA; Szymanski S; Safferman AZ; Pollack S; Cooper T; Kane JM; Lieberman JA
    Am J Psychiatry; 1995 Feb; 152(2):179-82. PubMed ID: 7840349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once-daily versus divided dosing regimens of clozapine: A cross-sectional study in Singapore.
    Yang Z; Takeuchi H; Yee JY; See YM; Tang C; Ng BT; Lee J
    Schizophr Res; 2024 Jun; 268():66-73. PubMed ID: 37833207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical use of plasma clozapine levels.
    Bell R; McLaren A; Galanos J; Copolov D
    Aust N Z J Psychiatry; 1998 Aug; 32(4):567-74. PubMed ID: 9711372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine and norclozapine concentrations in serum and plasma samples from schizophrenic patients.
    Hermida J; Paz E; Tutor JC
    Ther Drug Monit; 2008 Feb; 30(1):41-5. PubMed ID: 18223461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term pharmacokinetics of clozapine.
    Kurz M; Hummer M; Kemmler G; Kurzthaler I; Saria A; Fleischhacker WW
    Br J Psychiatry; 1998 Oct; 173():341-4. PubMed ID: 9926040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged <18 years: data from a therapeutic drug monitoring service, 1994-2010.
    Couchman L; Bowskill SV; Handley S; Patel MX; Flanagan RJ
    Early Interv Psychiatry; 2013 May; 7(2):122-30. PubMed ID: 22747759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of clozapine and norclozapine in Mexican schizophrenia patients.
    González-Esquivel DF; Castro N; Ramírez-Bermúdez J; Custodio V; Rojas-Tomé S; Castro-Román R; Jung-Cook H
    Arzneimittelforschung; 2011; 61(6):335-9. PubMed ID: 21827043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of variable cigarette consumption on the interaction with clozapine and olanzapine.
    Haslemo T; Eikeseth PH; Tanum L; Molden E; Refsum H
    Eur J Clin Pharmacol; 2006 Dec; 62(12):1049-53. PubMed ID: 17089108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine: in prevention of suicide in patients with schizophrenia or schizoaffective disorder.
    Wagstaff A; Perry C
    CNS Drugs; 2003; 17(4):273-80; discussion 281-3. PubMed ID: 12665398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone augmentation of clozapine: a critical review.
    Kontaxakis VP; Ferentinos PP; Havaki-Kontaxaki BJ; Paplos KG; Pappa DA; Christodoulou GN
    Eur Arch Psychiatry Clin Neurosci; 2006 Sep; 256(6):350-5. PubMed ID: 16900439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine serum concentrations in dopamimetic psychosis in Parkinson's disease and related disorders.
    Lutz UC; Sirfy A; Wiatr G; Altpass D; Farger G; Gasser T; Karle KN; Batra A
    Eur J Clin Pharmacol; 2014 Dec; 70(12):1471-6. PubMed ID: 25323805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey.
    Zimmet SV; Strous RD; Burgess ES; Kohnstamm S; Green AI
    J Clin Psychopharmacol; 2000 Feb; 20(1):94-8. PubMed ID: 10653215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.